Nyxoah SA
NYXHNASDAQHealthcareMedical Instruments & Supplies
As of Oct 26, 2026 close
- Market cap
- $48.83M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.90$5.96
- Volume (live)
- -
- Avg. volume (3M)
- 208.03K
Nyxoah SA (NYXH) Stock Price & Financial Analysis
Nyxoah SA Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.81 - $0.86 |
|---|---|
| 52-Week High | $5.96 |
| 52-Week Low | $0.90 |
| Open | $0.84 |
| Volume (last close) | 232.40K |
| Average Volume (3M) | 208.03K |
| Revenue (TTM) | 24.19M |
|---|---|
| Net Income (TTM) | -107.22M |
| Free Cash Flow (TTM) | -82.54M |
| EPS (TTM) | −$2.41 |
| Profit Margin | -443.16% |
| Operating Margin | -385.46% |
| Return on Equity (ROE) | -115.51% |
| Debt to Equity | 0.61 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 48.83M |
|---|---|
| Shares Outstanding | 57.01M |
| Price to Sales (P/S) | 2.02 |
| Price to Book (P/B) | 0.53 |
| EV/EBITDA | -0.34 |
| 50-Day MA | $1.46 |
|---|---|
| 200-Day MA | $2.66 |
| 1-Year Change | −85.50% |
Source: Market prices and company fundamentals. Data as of Oct 26, 2026. Data sources and methodology
Nyxoah SA at a Glance
As of the Oct 26, 2026 close, Nyxoah SA (NYXH) has a market capitalization of $48.83M. The stock trades at 2.0× sales. Over the trailing twelve months it lost $107.22M on revenue of $24.19M and burned $82.54M of free cash flow. Revenue grew 339.1% year over year.
As of its latest reported balance sheet, it holds $71.61M in cash and securities against $56.61M of debt, a net cash position of $14.99M.
Nyxoah SA does not currently pay a dividend.
The share price is down 85.5% over the past year. At $0.86 (the Oct 26, 2026 close) it sits near the bottom of its 52-week range of $0.90 to $5.96, below its 200-day moving average of $2.66.
Based on 6 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $4.26, 397.4% above the Oct 26, 2026 close.
Frequently Asked Questions About Nyxoah SA
What is the current stock price for NYXH?
As of the Oct 26, 2026 close, NYXH stock trades at $0.86. The 52-week range is $0.90–$5.96, with a day range of $0.81–$0.86.
What is the P/E ratio for NYXH?
The P/E ratio (Price-to-Earnings) for NYXH is shown in the Key Statistics section. This valuation metric helps compare Nyxoah SA to industry peers.
Does NYXH pay dividends?
Nyxoah SA does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for NYXH?
Based on ratings from 6 professional analysts over the last 90 days, the consensus for NYXH is Buy. The average 12-month price target is $4.26, a 397.4% upside from the Oct 26, 2026 close of $0.86.
What is the market cap of NYXH?
As of the Oct 26, 2026 close, Nyxoah SA's market capitalization is $48.8M, classifying it as a micro-cap company. Nyxoah SA operates in the Healthcare sector within the Medical Instruments & Supplies industry.